The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression
暂无分享,去创建一个
Yong-Ku Kim | Kyoung-Sae Na | B. Leonard | Yong-Ku Kim | A. Myint | Kyoung-Sae Na | Brian E. Leonard | Aye-Mu Myint
[1] C. Blatteis,et al. Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs , 1983, Brain Research Bulletin.
[2] B. Aggarwal,et al. Inflammation and cancer: how hot is the link? , 2006, Biochemical pharmacology.
[3] D. Keating. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases , 2007, Journal of neurochemistry.
[4] S. Lehnardt,et al. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.
[5] Wolfgang Schreiber,et al. Hormonal Response Pattern in the Combined DEX-CRH Test Is Stable over Time in Subjects at High Familial Risk for Affective Disorders , 1998, Neuropsychopharmacology.
[6] B. Ravnkilde,et al. Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.
[7] J. Cidlowski,et al. The Physiology of Human Glucocorticoid Receptor β (hGRβ) and Glucocorticoid Resistance , 2006 .
[8] M. Mattson,et al. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes , 1997, Neuroscience.
[9] R. Sapolsky,et al. Glucocorticoids Exacerbate Lipopolysaccharide-Induced Signaling in the Frontal Cortex and Hippocampus in a Dose-Dependent Manner , 2010, The Journal of Neuroscience.
[10] A. Hruszkewycz. Lipid peroxidation and mtDNA degeneration. A hypothesis. , 1992, Mutation research.
[11] M. Matzuk,et al. Glutathione synthesis is essential for mouse development but not for cell growth in culture. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] Jin H. Song,et al. Interferon γ Induces Neurite Outgrowth by Up-regulation of p35 Neuron-specific Cyclin-dependent Kinase 5 Activator via Activation of ERK1/2 Pathway* , 2005, Journal of Biological Chemistry.
[13] W. Banks,et al. Brain-immune communication pathways , 2007, Brain, Behavior, and Immunity.
[14] P. Patterson,et al. Leukemia inhibitory factor is a key regulator of astrocytic, microglial and neuronal responses in a low-dose pilocarpine injury model , 2006, Brain Research.
[15] R. Dantzer,et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice , 2009, Molecular Psychiatry.
[16] M. Maes,et al. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.
[17] Y. Nolan,et al. Tumour necrosis factor-α impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1 , 2010, Molecular and Cellular Neuroscience.
[18] O. Wolkowitz,et al. Dysregulated relationship of inflammation and oxidative stress in major depression , 2013, Brain, Behavior, and Immunity.
[19] R. Sapolsky,et al. Novel glucocorticoid effects on acute inflammation in the CNS , 2003, Journal of neurochemistry.
[20] Andrew H. Miller,et al. Cytokines and Glucocorticoid Receptor Signaling , 2009, Annals of the New York Academy of Sciences.
[21] M. Drew,et al. Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression , 2009, Neuron.
[22] T. Ushijima,et al. Enhanced IL‐1β production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice , 2010, Synapse.
[23] Deborah A Yurgelun-Todd,et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study , 2000, Biological Psychiatry.
[24] Andiara E. Freitas,et al. TNF-α-induced depressive-like phenotype and p38MAPK activation are abolished by ascorbic acid treatment , 2015, European Neuropsychopharmacology.
[25] N. Herrmann,et al. A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.
[26] B. Leonard. Inflammation, Depression and Dementia: Are they Connected? , 2007, Neurochemical Research.
[27] Anthony J. Cleare,et al. Different responses to dexamethasone and prednisolone in the same depressed patients , 2006, Psychopharmacology.
[28] Jiankun Cui,et al. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia , 2011, Journal of Neuroinflammation.
[29] O. Andreassen,et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery , 2014, Psychoneuroendocrinology.
[30] S. Szanton,et al. Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies , 2014, Psychosomatic medicine.
[31] G. Chrousos,et al. Tumor Necrosis Factor α Receptor- and Fas-associated FLASH Inhibit Transcriptional Activity of the Glucocorticoid Receptor by Binding to and Interfering with Its Interaction with p160 Type Nuclear Receptor Coactivators* , 2003, The Journal of Biological Chemistry.
[32] G. Kreutzberg,et al. Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.
[33] M. Woodroofe. Cytokine production in the central nervous system , 1995, Neurology.
[34] A. Mouihate. TLR4-mediated brain inflammation halts neurogenesis: impact of hormonal replacement therapy , 2014, Front. Cell. Neurosci..
[35] Edward T. Bullmore,et al. Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections , 2010, PloS one.
[36] J. Sheridan,et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia , 2008, Journal of Neuroinflammation.
[37] F. J. Monje,et al. Long-term effects of maternal immune activation on depression-like behavior in the mouse , 2014, Translational Psychiatry.
[38] J. Altman,et al. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.
[39] R. Sapolsky,et al. Glucocorticoids Increase Excitotoxic Injury and Inflammation in the Hippocampus of Adult Male Rats , 2014, Neuroendocrinology.
[40] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[41] N. Sousa,et al. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement , 2000, Neuroscience.
[42] S. Bilbo,et al. Early-Life Programming of Later-Life Brain and Behavior: A Critical Role for the Immune System , 2009, Front. Behav. Neurosci..
[43] A. Hariri,et al. A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology , 2013, Molecular Psychiatry.
[44] J. Cidlowski,et al. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Joëls,et al. Brain corticosteroid receptor balance in health and disease. , 1998, Endocrine reviews.
[46] C. Pariante,et al. Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis , 2012, Neuropsychopharmacology.
[47] J. Ting,et al. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.
[48] B. Binder,et al. Constant Darkness Induces IL-6-Dependent Depression-Like Behavior through the NF-κB Signaling Pathway , 2011, The Journal of Neuroscience.
[49] R. Dantzer,et al. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior , 2002, Journal of Neuroimmunology.
[50] J. Herbert,et al. The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus , 2004, The European journal of neuroscience.
[51] David A Padgett,et al. How stress influences the immune response. , 2003, Trends in immunology.
[52] Olga V. Demler,et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[53] B. Vollmayr,et al. Neurogenesis and depression: etiology or epiphenomenon? , 2004, Biological Psychiatry.
[54] B. Yu,et al. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. , 1994, Free radical biology & medicine.
[55] H. Steinbusch,et al. Kynurenine pathway in major depression: evidence of impaired neuroprotection. , 2007, Journal of affective disorders.
[56] A. Miller,et al. Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function , 2005, Molecular Psychiatry.
[57] I. Adcock,et al. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.
[58] Freya Q. Schafer,et al. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.
[59] B. Leonard. Psychopathology of depression. , 2007, Drugs of today.
[60] D. Ferriero,et al. Selective vulnerability in the developing central nervous system. , 2004, Pediatric neurology.
[61] J. Davis,et al. DST studies in psychotic depression: a meta-analysis. , 1997, The American journal of psychiatry.
[62] Andrew H. Miller,et al. When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders , 2003 .
[63] Toshiyuki Someya,et al. Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats , 2004, Neuroscience Research.
[64] Gerd Kempermann,et al. Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells , 2005, Progress in Neurobiology.
[65] A. Vercesi,et al. Mitochondrial damage induced by conditions of oxidative stress. , 1999, Free radical biology & medicine.
[66] J. Koo,et al. IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress , 2008, Proceedings of the National Academy of Sciences.
[67] Henrik Ahlenius,et al. Tumor Necrosis Factor Receptor 1 Is a Negative Regulator of Progenitor Proliferation in Adult Hippocampal Neurogenesis , 2006, The Journal of Neuroscience.
[68] K. Kisich,et al. A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance1 , 2002, The Journal of Immunology.
[69] H. Flor,et al. Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive Reactions , 2005, The Journal of Neuroscience.
[70] H. Hansson,et al. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[71] G. Ramadori,et al. Glucocorticoid receptor signaling in the intestinal epithelial cell lines IEC-6 and Caco-2: evidence of inhibition by interleukin-1β , 2001, International Journal of Colorectal Disease.
[72] F. Dhabhar,et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions , 1997, Brain Research Reviews.
[73] T. Kishimoto,et al. Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.
[74] L. Staib,et al. Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.
[75] O. Fattal,et al. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. , 2006, Psychosomatics.
[76] T. Ternynck,et al. Interleukin‐1 Receptor Defect in Autoimmune NZB Mouse Brain , 1998, Annals of the New York Academy of Sciences.
[77] I. Goshen,et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.
[78] Anne E Carpenter,et al. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. , 2010, The American journal of pathology.
[79] M. Maes,et al. The role of the cytokine network in psychological stress , 2003, Acta Neuropsychiatrica.
[80] M. Maes,et al. Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. , 2002, Journal of affective disorders.
[81] W. Banks,et al. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier , 1989, Brain Research Bulletin.
[82] F. Pitossi,et al. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice , 1997, Journal of neuroscience research.
[83] D. Umetsu,et al. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. , 1997, Journal of immunology.
[84] J. P. Hamilton,et al. Decreased hippocampal volume in healthy girls at risk of depression. , 2010, Archives of general psychiatry.
[85] M. Zhuo,et al. The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior , 2008, The Journal of Neuroscience.
[86] F. Gage,et al. Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.
[87] S. Mukherjee,et al. Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.
[88] V. Ferrans,et al. Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.
[89] J. Price,et al. Neurocircuitry of Mood Disorders , 2010, Neuropsychopharmacology.
[90] Z. Szatmáry,et al. Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase* , 2004, Journal of Biological Chemistry.
[91] B. Leonard,et al. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[92] Andrew H. Miller,et al. Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression , 2007, Brain, Behavior, and Immunity.
[93] C. Pariante,et al. Effects of Cytokines on Glucocorticoid Receptor Expression And Function , 1999 .
[94] M. Maj,et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.
[95] R. Hirschfeld. History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.
[96] Gustavo Turecki,et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse , 2009, Nature Neuroscience.
[97] C. Pariante,et al. Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells , 2015, The international journal of neuropsychopharmacology.
[98] M. Szyf,et al. Differential Glucocorticoid Receptor Exon 1B, 1C, and 1H Expression and Methylation in Suicide Completers with a History of Childhood Abuse , 2012, Biological Psychiatry.
[99] D. Miller. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule. , 2001, The Journal of pharmacology and experimental therapeutics.
[100] R. Duman. Depression: a case of neuronal life and death? , 2004, Biological Psychiatry.
[101] C. Kirschbaum,et al. Determinants of the NF-κB response to acute psychosocial stress in humans , 2009, Brain, Behavior, and Immunity.
[102] Yong-Ku Kim,et al. Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[103] W. Pan,et al. TNFα Transport across the Blood–Brain Barrier Is Abolished in Receptor Knockout Mice , 2002, Experimental Neurology.
[104] J. Licinio,et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs , 2002, Molecular Psychiatry.
[105] B. Baune,et al. TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice , 2013, Psychoneuroendocrinology.
[106] N. Decarolis,et al. Hippocampal neurogenesis as a target for the treatment of mental illness: A critical evaluation , 2010, Neuropharmacology.
[107] A. Miller,et al. Interleukin 1α (IL-1α) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function , 2004, Molecular Psychiatry.
[108] L. Qi,et al. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics , 2009, Psychopharmacology.
[109] D. Barber,et al. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor. , 2004, Experimental cell research.
[110] M. Werner,et al. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats , 2014, Behavioural Brain Research.
[111] R. Ferrell,et al. Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment , 2013, Neuropsychopharmacology.
[112] H. Son,et al. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro , 2004, Brain Research.
[113] H. Akil,et al. Mineralocorticoid receptor function in major depression. , 2003, Archives of general psychiatry.
[114] Angela L. Lee,et al. Stress and depression: possible links to neuron death in the hippocampus. , 2002, Bipolar disorders.
[115] Gerd Kempermann,et al. Why New Neurons? Possible Functions for Adult Hippocampal Neurogenesis , 2002, The Journal of Neuroscience.
[116] R. Krishnan,et al. The Relation of Severity of Depressive Symptoms to Monocyte-Associated Proinflammatory Cytokines and Chemokines in Apparently Healthy Men , 2003, Psychosomatic medicine.
[117] I. Dybedal,et al. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. , 2001, Blood.
[118] G. Kenis,et al. Effects of antidepressants on the production of cytokines. , 2002, The international journal of neuropsychopharmacology.
[119] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[120] K. Do,et al. New model of glutathione deficit during development: Effect on lipid peroxidation in the rat brain , 2002, Journal of neuroscience research.
[121] Carl Nathan,et al. Points of control in inflammation , 2002, Nature.
[122] Guo-Yuan Yang,et al. Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia , 2004, Brain Research.
[123] H. Monyer,et al. NMDA receptor channels: Subunit-specific potentiation by reducing agents , 1994, Neuron.
[124] A. S. Clark,et al. Anabolic-androgenic steroid and adrenal steroid effects on hippocampal plasticity , 1995, Brain Research.
[125] T. Jernigan,et al. Hippocampal volume changes in healthy subjects at risk of unipolar depression. , 2010, Journal of psychiatric research.
[126] Lili Zhou,et al. Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling , 2014, Journal of Neuroinflammation.
[127] B. Ham,et al. Association between Glucocorticoid Receptor Methylation and Hippocampal Subfields in Major Depressive Disorder , 2014, PloS one.
[128] E. Gould,et al. Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus , 1998, International Journal of Developmental Neuroscience.
[129] Yong-Ku Kim,et al. Cytokine imbalance in the pathophysiology of major depressive disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[130] E. Nestler,et al. Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior , 2010, Proceedings of the National Academy of Sciences.
[131] M. O’Banion,et al. Adult murine hippocampal neurogenesis is inhibited by sustained IL-1β and not rescued by voluntary running , 2012, Brain, Behavior, and Immunity.
[132] Yong-Ku Kim,et al. Role of cytokines in atypical depression , 2012, Nordic journal of psychiatry.
[133] Michael J Meaney,et al. Epigenetic programming by maternal behavior , 2004, Nature Neuroscience.
[134] P. Riederer,et al. The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[135] R. Dempsey,et al. Adult interleukin-6 knockout mice show compromisedneurogenesis , 2011, Neuroreport.
[136] Depression in patients with rheumatoid arthritis: description, causes and mechanisms. , 2011 .
[137] A. Nagai,et al. Cytokines, chemokines, and cytokine receptors in human microglia , 2002, Journal of neuroscience research.
[138] Hongjun Song,et al. Adult neurogenesis in the mammalian central nervous system. , 2005, Annual review of neuroscience.
[139] T. Ben-Hur,et al. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells , 2003, Molecular and Cellular Neuroscience.
[140] W. Banks,et al. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide , 2006, Brain, Behavior, and Immunity.
[141] R. Dantzer,et al. Inactivation of the Cerebral NFκB Pathway Inhibits Interleukin-1β-Induced Sickness Behavior and c-Fos Expression in Various Brain Nuclei , 2005, Neuropsychopharmacology.
[142] C. Pariante,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Proinflammatory Cytokine, Interleukin-1�, Reduces , 2022 .
[143] C. Kellendonk,et al. Genetic dissection of glucocorticoid receptor function in mice. , 1998, Current opinion in genetics & development.
[144] Han-Yong Jung,et al. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[145] R. Sapolsky,et al. The Stressed CNS: When Glucocorticoids Aggravate Inflammation , 2009, Neuron.
[146] M. Pfisterer,et al. Coronary artery disease and depression. , 2004, European heart journal.
[147] M. Fresno,et al. The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system , 1998, Progress in Neurobiology.
[148] D. Mason,et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. , 1996, Journal of immunology.
[149] Charles L. Raison,et al. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.
[150] A. Meister. Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.
[151] Hiroki Toda,et al. Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.
[152] J. Mendels,et al. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. , 1976, Archives of general psychiatry.
[153] A. Kraft,et al. Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment , 2008, Expert opinion on drug metabolism & toxicology.
[154] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[155] R. S. Smith. The macrophage theory of depression. , 1991, Medical hypotheses.
[156] L. Galea,et al. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats , 2010, Neuroscience.
[157] R. Duman,et al. A Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment , 2007, Biological Psychiatry.
[158] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[159] F. Holsboer,et al. The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation. , 1998, Journal of psychiatric research.
[160] Fritz A. Henn,et al. Neurogenesis and depression: what animal models tell us about the link , 2007, European Archives of Psychiatry and Clinical Neuroscience.
[161] William A Banks,et al. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. , 2005, Current pharmaceutical design.
[162] S. Kanba,et al. Suppression of Cell Proliferation by Interferon-Alpha through Interleukin-1 Production in Adult Rat Dentate Gyrus , 2006, Neuropsychopharmacology.
[163] J. Gensel,et al. Immune Activation Promotes Depression 1 Month After Diffuse Brain Injury: A Role for Primed Microglia , 2014, Biological Psychiatry.